{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:00:35Z","timestamp":1787014835712,"version":"build-2736575974"},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T00:00:00Z","timestamp":1218153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    The exact incidence and prevalence of Budd\u2010Chiari syndrome (BCS) is unknown in the general population. Published reports differ in terms of the clinical characteristics, effects of therapy and survival.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Aims:<\/jats:bold>\n                    To investigate the epidemiology, clinical presentation and survival in patients with BCS.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Retrospective multicentre study in Sweden reviewing the medical records of all patients with BCS 1986\u20132003, identified from the computerised diagnosis database of 11 hospitals, including all university hospitals and liver transplantation centres.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Forty\u2010three patients with BCS were identified, of whom nine (21%) had concomitant portal vein thrombosis. The mean age\u2010standardised incidence and prevalence rates in 1990\u20132001 were calculated to be 0.8 per million per year and 1.4 per million inhabitants respectively. Myeloproliferative disorders (38%), thrombophilic factors (31%) and oral contraceptives (30%) were common aetiological factors. Two or more risk factors were present in 44%. In 23%, no risk factor was evident. The median follow\u2010up time was 2.7 years. Seventy\u2010two percent were on anticoagulant therapy during follow\u2010up. Transjugular intrahepatic portosystemic shunting, surgical shunting procedures and liver transplantation were performed in 4, 6 and 18 patients respectively. Nineteen patients died. The overall transplantation\u2010free survival at 1, 5 and 10 years was 47, 28 and 17% respectively.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Budd\u2010Chiari syndrome is a rare disorder; the mean age\u2010standardised incidence and prevalence rates in Sweden in 1990\u20132001 were calculated to be 0.8 per million per year and 1.4 per million inhabitants respectively. The presence of a myeloproliferative disorder was a common aetiological factor in our cohort and about half of the patients had a multifactorial aetiology. The transplantation\u2010free survival was poor.\n                  <\/jats:p>","DOI":"10.1111\/j.1478-3231.2008.01838.x","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T00:56:42Z","timestamp":1269910602000},"page":"253-259","source":"Crossref","is-referenced-by-count":109,"title":["Budd\u2010Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival \u2013 an 18\u2010year experience"],"prefix":"10.1111","volume":"29","author":[{"given":"Rupesh","family":"Rajani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Melin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Broom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Sangfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5ke","family":"Danielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Gustavsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Grip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"L\u00f6\u00f6f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Wallerstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven HC","family":"Almer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,6]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"364","article-title":"Budd\u2010Chiari syndrome","volume":"38","author":"Janssen HL","year":"2003","journal-title":"a review by an expert panel"},{"key":"e_1_2_6_3_2","first-page":"1042","article-title":"The changing scene of hepatic vein thrombosis","volume":"106","author":"Hadengue A","year":"1994","journal-title":"recognition of asymptomatic cases"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020282"},{"key":"e_1_2_6_5_2","first-page":"587","article-title":"Cause of portal or hepatic venous thrombosis in adults","volume":"31","author":"Denninger MH","year":"2000","journal-title":"the role of multiple concurrent factors"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20064"},{"key":"e_1_2_6_7_2","first-page":"84","article-title":"Outcome of Budd\u2010Chiari syndrome","volume":"30","author":"Zeitoun G","year":"1999","journal-title":"a multivariate analysis of factors related to survival including surgical portosystemic shunting"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80252-5"},{"key":"e_1_2_6_9_2","first-page":"204","article-title":"Hepatic venous outflow tract obstruction etiopathogenesis","volume":"19","author":"Valla D.","year":"2004","journal-title":"Asia versus the West"},{"key":"e_1_2_6_10_2","first-page":"650","article-title":"Incidence of parenchymal liver diseases in Denmark, 1981 to 1985","volume":"13","author":"Almdal TP","year":"1991","journal-title":"analysis of hospitalization registry data. The Danish Association for the Study of the Liver"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21354"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00353.x"},{"key":"e_1_2_6_13_2","first-page":"1","article-title":"The person\u2010number systems of Sweden, Norway, Denmark, and Israel","volume":"2","author":"Lunde AS","year":"1980","journal-title":"Vital Health Stat"},{"key":"e_1_2_6_14_2","volume-title":"Epidemiologiskt Centrum, Patientregistret 1964\u20132005 Kvalitet och inneh\u00e5ll","author":"Socialstyrelsen \u2013 State department of National Health and Welfare.","year":"2006"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-3-329"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.04.008"},{"key":"e_1_2_6_17_2","first-page":"1712","article-title":"Myeloproliferative disease in the pathogenesis and survival of Budd\u2010Chiari syndrome","volume":"91","author":"Smalberg JH","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.6.798"},{"key":"e_1_2_6_19_2","first-page":"520","article-title":"Liver transplantation for Budd\u2010Chiari syndrome","volume":"44","author":"Mentha G","year":"2006","journal-title":"a European study on 248 patients from 51 centres"},{"key":"e_1_2_6_20_2","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd\u2010Chiari syndrome and portal vein thrombosis","volume":"96","author":"Janssen HL","year":"2000","journal-title":"results of a case\u2013control study"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90855-3"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199705000-00014"},{"key":"e_1_2_6_23_2","first-page":"455","article-title":"Budd\u2010Chiari syndrome","volume":"28","author":"Horton JD","year":"2008","journal-title":"illustrated review of current management"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2008.01838.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2008.01838.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:28:39Z","timestamp":1697236119000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2008.01838.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,6]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1478-3231.2008.01838.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01838.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,6]]}}}